Network News
Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses Paris, June 23, 2026. The European Commission has approved Cenrifki (tolebrutinib) for the treatment of secondary progressive multiple sclerosis (SPMS) without relapses in the last two years. This follows the positive opinion by the European Medicines Agency’s Committee […]
read more
Fraunhofer IPA and LMU Medical Center Unveil Robotic Assistance System for Pediatric Medicine
The health status of children admitted to the hospital after a mild traumatic brain injury must be closely monitored. The two project partners have developed a robot that can assist staff with routine health checks on these patients. Full text in German below. Fraunhofer IPA und LMU Klinikum präsentieren robotisches Assistenzsystem für die Kindermedizin Pressemitteilung […]
read more
Tailor-made functionalized gelatin – manufactured with reproducible results
Gelatin is a versatile natural material. To tailor its properties specifically to the requirements of various applications in medicine, diagnostics, and cosmetics, the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has developed a toolbox for chemical functionalization. With the help of automated processes, the modifications can now be scaled under defined conditions, and reproducible […]
read more
AI agent MIRA supports clinical workflows in electronic health records as a co-pilot
Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology and University Hospital Dresden present the next stage of medical AI in a new study published in Nature. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and Heidelberg University Hospital were also involved. The team led […]
read more
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
ZURICH, SWITZERLAND – June 10, 2026 — VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, today announced that its previously announced business combination (“Business Combination”) with Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), a special purpose acquisition company sponsored by Cantor Fitzgerald & Co., Voyager Acquisition Sponsor Holdco LLC, and Odeon Capital Group LLC, was […]
read more
Complications after liver transplantation and leukemic niches: Heidelberg Faculty of Medicine honors outstanding early-career researchers
The Heidelberg Faculty of Medicine at Heidelberg University presented the Anita and Friedrich Reutner Prize for Medical Research and the Hoffmann-Klose Prize for an outstanding Clinician Scientist project at this year’s Faculty Day – an event bringing together students, researchers, and teaching staff. The award recipients, Christine Zhang-Hagenlocher and Kristina Müller, are early-career physician-scientists From […]
read more
AI Diagnoses Brain Tumors in Minutes Instead of Weeks
Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system identifies more than 100 molecular subtypes of central nervous system tumors, delivers results within minutes, and could accelerate the diagnosis of brain tumors worldwide. Tumors of the brain […]
read more
CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice
Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]
read more
Fat hack protects against cell death
In response to stress or damage, cells undergo senescence and stop dividing. However, if senescent cells accumulate in tissues over the long term, chronic inflammation occurs and the risk of cancer increases. Researchers at the German Cancer Research Center (DKFZ) have now discovered a previously unknown mechanism by which senescent cells protect themselves from oxidative […]
read more
